Ablaze Pharma
ClosedAblaze Pharma is a biotech company. It has raised $75.0M across 1 round, most recently a $75.0M Series A in November 2021.
- Website
- ablazepharma.com
- Total Funding
- $75.0M
- Last Round
- $75.0M Series ANov 2021
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 4 investors for this company. The full record is or through the API.
About
Public company, acquired by Bristol Myers Squibb
Summary
It has raised $75.0M in total across 1 round, most recently a $75.0M Series A round in Nov 2021. Investors include Vivo Capital, Advantech Capital and Nan Fung Life Sciences.
Funding History
Nov 2021
Investors
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ablaze-pharma"><img src="https://indexed.vc/api/badge/company/ablaze-pharma" alt="Ablaze Pharma on Indexed.vc" width="260" height="76" /></a>